Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 10 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Radha G.

India

USD 10 /hr

Freelance Scientific Content writing, Reviewing, Proof reading and Editing - 15 + years experience - Infectious Diseases

Profile Summary

I have 15 years of experience in the field of Infctious Diseases (tuberculosis/mycobacteriology) and 8 years in developing cell-free and cell-based assays for new drug discovery for various therapeutic areas. I have immense experience and knowledge in the field of diagnosis of pulmonary and extrapulmonary tuberculosis, non-tuberculous mycobacteria; molecular diagnosis including next generation sequencing for detection of drug resistance. I have a great passion for scientific writing, reviewing, and editing that has driven me to serve as an editorial board member, ad-hoc reviewer and guest editor for peer-reviewed journals

Subject Matter Expertise

• ☆ Molecular Biology
• ☆ DNA Sequencing
• ☆ Infectious Disease
• ☆ Pulmonology/Respiratory Disease
• ☆ Tuberculosis

Services

• Writing
• Research
• Consulting

Writing Technical Writing, General Proofreading & Editing

Research Gray Literature Search, Scientific and Technical Research

Consulting Scientific and Technical Consulting

Work Experience

Biotechnologist - National Reference Laboratory, National Tuberculosis Elimination Program

National Institute of Research in Tuberculosis

June 2020 - Present

Scientist - Chennai Cambridge collaborative study

National Institute of Research in Tuberculosis

September 2017 - June 2019

Scientist - In vitro Assay Development

Orchid Pharma Ltd

April 2009 - June 2017

Post doctoral Researcher

University of British Columbia

October 2006 - June 2008

Education

Ph D (Immunology/ Molecular Biology/Bio-Medical Genetics) (Immunology)

National Institute of Research in Tuberculosis

July 2000 - September 2006

M. Sc Bio-Medical Genetics (Genetics)

University of Madras - Institute of Basic Medical Sciences

June 1998 - May 2000

B. Sc Zoology (Zoology)

Justice Basheer Ahmed Sayeed College for Women

June 1995 - May 1998

Certifications

• PhD

  University of Madras

  January 2000 - January 2006

Publications

JOURNAL ARTICLE

Radha Gopalaswamy, Selvakumar Subbian (2025). Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence? . Journal of Respiration.

Radha Gopalaswamy, Selvakumar Subbian (2025). Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence? . Journal of Respiration.

Radha Gopalaswamy, Bhargavi Subramanian, Manisha Parthasarathy, Chandrasekaran Padmapriyadarsini, Sivakumar Shanmugam (2025). Direct targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis from clinical samples – An update . Indian Journal of Tuberculosis.

Radha Gopalaswamy, Vivekanandhan Aravindhan, Selvakumar Subbian (2024). The Ambivalence of Post COVID-19 Vaccination Responses in Humans . Biomolecules.

Radha Gopalaswamy, Vivekanandhan Aravindhan, Selvakumar Subbian (2024). The Ambivalence of Post COVID-19 Vaccination Responses in Humans . Biomolecules.

Radha Gopalaswamy, Nishant Kumar, Himanshu Vashistha, Priya Rajendran, Jyoti Kayesth, Carel Joseph Peravali, Satabdi Kashyap, Shreeparna Ghosh, Habakkuk Yumo, Moe Moore, et al. (2023). Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India . Frontiers in Public Health.

Radha Gopalaswamy, Nandhini Palani, Dinesh Viswanathan, Bershila Preysingh, Suchithra Rajendran, Vaishnavee Vijayaraghavan, Kannadasan Thangavel, Senthil Devi Vadivel, Hannah Stanley, Kannan Thiruvengadam, et al. (2023). Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India . Medicina.

Radha Gopalaswamy, Nandhini Palani, Dinesh Viswanathan, Bershila Preysingh, Suchithra Rajendran, Vaishnavee Vijayaraghavan, Kannadasan Thangavel, Senthil Devi Vadivel, Hannah Stanley, Kannan Thiruvengadam, et al. (2023). Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India . Medicina.

Radha Gopalaswamy and Bhargavi Subramanian and Padmapriyadarsini Chandrasekaran and Siva Kumar Shanmugam(2022). An odyssey from laboratory to field ? – Portable tNGS system for TB diagnosis in programmatic setting . Indian Journal of Tuberculosis. Elsevier {BV}

Radha Gopalaswamy, V. N. Azger Dusthackeer, Silambuchelvi Kannayan, Selvakumar Subbian(2021). Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance . Journal of Respiration. 1. (2). p. 141--164. {MDPI} {AG}

Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium tuberculosis Infection <head> <META HTTP-EQUIV="Refresh" CONTENT="0;URL=/servlet/useragent"> </head> . Medicina.

(2021). Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases . International Journal of Tuberculosis and Lung Disease.

Radha Gopalaswamy, V. N. Azger Dusthackeer, Silambuchelvi Kannayan, Selvakumar Subbian (2021). Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance . Journal of Respiration.

Radha Gopalaswamy, Harresh Adikesavalu, Ashok Kumar, Uma Devi Ranganathan, Sivakumar Shanmugam (2021). Autophagy Induction as a Host-Directed Therapeutic Strategy against <i>Mycobacterium tuberculosis</i> Infection . Medicina.

Radha Gopalaswamy, Selvakumar Subbian (2021). Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis . International Journal of Molecular Sciences.

Radha Gopalaswamy, Selvakumar Subbian (2021). Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis . International Journal of Molecular Sciences.

(2021). Pulmonary Mycobacterium abscessus and response to treatment in an outpatient setting: Case series . International Journal of Mycobacteriology.

Radha Gopalaswamy, Natarajan Ganesan, Kalamani Velmurugan, Vivekanandhan Aravindhan, Selvakumar Subbian(2020). The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air . Vaccines. 8. (4). p. 612. {MDPI} {AG}

(2020). Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment . Journal of Biomedical Science.

Kristin N Adams and Amit Kumar Verma and Radha Gopalaswamy and Harresh Adikesavalu and Dinesh Kumar Singhal and Srikanth Tripathy and Uma Devi Ranganathan and David R Sherman and Kevin B Urdahl and Lalita Ramakrishnan and Rafael E Hernandez(2019). Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance . The Journal of Infectious Diseases. 219. (10). p. 1554--1558. Oxford University Press ({OUP})

Srinivasan Kandasamy and Sameer Hassan and Radha Gopalaswamy and Sujatha Narayanan(2014). Homology modelling, docking, pharmacophore and site directed mutagenesis analysis to identify the critical amino acid residue of PknI from Mycobacterium tuberculosis . Journal of Molecular Graphics and Modelling. 52. p. 11--19. Elsevier {BV}

Srinivasan Kandasamy and Sameer Hassan and Radha Gopalaswamy and Sujatha Narayanan(2014). Homology modelling, docking, pharmacophore and site directed mutagenesis analysis to identify the critical amino acid residue of PknI from Mycobacterium tuberculosis . Journal of Molecular Graphics and Modelling. 52. p. 11--19. Elsevier {BV}

(2013). Functional characterization of Candida albicans Hos2 histone deacetylase. F1000 Research.

(2013). Functional characterization of Candida albicans Hos2 histone deacetylase. F1000 Research.

(2009). The serine/threonine protein kinase PknI controls the growth of Mycobacterium tuberculosis upon infection. FEMS Microbiol Letters.

(2008). Mycobacterium smegmatis biofilm formation and sliding motility are affected by the serine/threonine protein kinase PknF. FEMS Microbiol Letters.

(2004). Cloning, over expression and characterization of a serine/threonine protein kinase pknI from Mycobacterium tuberculosis H37Rv. Protein Expression and Purification.

BOOK CHAPTER

Radha Gopalaswamy and Selvakumar Subbian(2022). An Update on Tuberculosis Vaccines . Vaccine Design. p. 387--409. Springer {US}